PHILADELPHIA - On 2-1 votes in four related cases, a Pennsylvania Superior Court panel on July 29 largely affirmed that many claims involving Reglan and its generic version metoclopramide are not preempted by federal law (Paul E. Hassett v. Donald Dafoe, M.D., et al., No. 81 EDA 2012, In Re: Reglan/Metoclopramide Litigation, Nos. 82 EDA 2012, 83 EDA 2012 and 84 EDA 2012, Pa. Super.).